- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.62 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.2: 4 residues within 4Å:- Chain A: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.52, A:N.54, A:V.57, A:E.62, H2O.1, H2O.1
CA.13: 5 residues within 4Å:- Chain B: Q.31, T.32
- Chain H: Q.31, T.32
- Ligands: CA.64
No protein-ligand interaction detected (PLIP)CA.19: 4 residues within 4Å:- Chain C: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.52, C:N.54, C:V.57, C:E.62, H2O.11, H2O.11
CA.30: 5 residues within 4Å:- Chain D: Q.31, T.32
- Chain F: Q.31, T.32
- Ligands: CA.47
No protein-ligand interaction detected (PLIP)CA.36: 4 residues within 4Å:- Chain E: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:E.52, E:N.54, E:V.57, E:E.62, H2O.21, H2O.21
CA.47: 5 residues within 4Å:- Chain D: Q.31, T.32
- Chain F: Q.31, T.32
- Ligands: CA.30
No protein-ligand interaction detected (PLIP)CA.53: 4 residues within 4Å:- Chain G: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain G, 2 Ligand-Water interactions- Metal complexes: G:E.52, G:N.54, G:V.57, G:E.62, H2O.31, H2O.31
CA.64: 5 residues within 4Å:- Chain B: Q.31, T.32
- Chain H: Q.31, T.32
- Ligands: CA.13
No protein-ligand interaction detected (PLIP)- 32 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: S.44
- Chain B: K.46
- Chain D: K.46
- Ligands: SO4.20
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: K.149, P.153, G.154
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: Q.33, K.89
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: S.75, N.77, T.80, N.82, N.83
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain B: R.42
- Chain C: K.69, K.89
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain B: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: K.46
- Chain C: S.44
- Chain D: K.46
- Ligands: SO4.3
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain C: K.149, P.153, G.154
Ligand excluded by PLIPSO4.22: 2 residues within 4Å:- Chain C: Q.33, K.89
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain C: S.75, N.77, T.80, N.82, N.83
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain D: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain A: K.69, K.89
- Chain D: R.42
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain D: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.37: 4 residues within 4Å:- Chain E: S.44
- Chain F: K.46
- Chain H: K.46
- Ligands: SO4.54
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain E: K.149, P.153, G.154
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain E: Q.33, K.89
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain E: S.75, N.77, T.80, N.82, N.83
Ligand excluded by PLIPSO4.48: 4 residues within 4Å:- Chain F: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain F: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Chain F: R.42
- Chain G: K.69, K.89
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain F: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain F: K.46
- Chain G: S.44
- Chain H: K.46
- Ligands: SO4.37
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain G: K.149, P.153, G.154
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain G: Q.33, K.89
Ligand excluded by PLIPSO4.57: 5 residues within 4Å:- Chain G: S.75, N.77, T.80, N.82, N.83
Ligand excluded by PLIPSO4.65: 4 residues within 4Å:- Chain H: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain H: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.67: 3 residues within 4Å:- Chain E: K.69, K.89
- Chain H: R.42
Ligand excluded by PLIPSO4.68: 4 residues within 4Å:- Chain H: P.9, Y.10, T.11, G.12
Ligand excluded by PLIP- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 6 residues within 4Å:- Chain A: C.109, A.110, I.142, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: N.19, Y.22, H.23, R.49, I.55, N.56
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: Y.5, C.7, T.11, L.117, C.137
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: I.30, N.31, K.217
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain C: C.109, A.110, I.142, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain C: N.19, Y.22, H.23, R.49, I.55, N.56
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain C: Y.5, C.7, T.11, L.117, C.137
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain C: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain C: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain C: I.30, N.31, K.217
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain E: C.109, A.110, I.142, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.42: 6 residues within 4Å:- Chain E: N.19, Y.22, H.23, R.49, I.55, N.56
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain E: Y.5, C.7, T.11, L.117, C.137
Ligand excluded by PLIPEDO.44: 4 residues within 4Å:- Chain E: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.45: 4 residues within 4Å:- Chain E: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.46: 3 residues within 4Å:- Chain E: I.30, N.31, K.217
Ligand excluded by PLIPEDO.58: 6 residues within 4Å:- Chain G: C.109, A.110, I.142, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.59: 6 residues within 4Å:- Chain G: N.19, Y.22, H.23, R.49, I.55, N.56
Ligand excluded by PLIPEDO.60: 5 residues within 4Å:- Chain G: Y.5, C.7, T.11, L.117, C.137
Ligand excluded by PLIPEDO.61: 4 residues within 4Å:- Chain G: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.62: 4 residues within 4Å:- Chain G: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain G: I.30, N.31, K.217
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hanson, W.M. et al., Rigidification of a Flexible Protease Inhibitor Variant upon Binding to Trypsin. J.Mol.Biol. (2007)
- Release Date
- 2006-02-14
- Peptides
- Cationic trypsin: ACEG
Pancreatic trypsin inhibitor: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EC
EE
EG
EB
ID
IF
IH
I
SMTL ID : 2ftl.2 (4 other biounits)
Crystal structure of trypsin complexed with BPTI at 100K
Cationic trypsin
Toggle Identical (ACEG)Pancreatic trypsin inhibitor
Toggle Identical (BDFH)Related Entries With Identical Sequence
1b0c.1 | 1bhc.1 | 1bpi.1 | 1bth.1 | 1bth.2 | 1bz5.1 | 1bzx.1 | 1cbw.1 | 1cbw.2 | 1cbw.3 | 1d0d.1 | 1eaw.1 | 1eaw.2 | 1fy8.1 | 1mtn.1 | 1mtn.2 | 1mtn.3 | 1oa5.1 | 1oa6.1 | 1pit.1 | 1tpa.1 | 1tpa.2 | 2fi4.1 | 2fi4.2 | 2fi4.3 | 2fi4.4 | 2fi4.5 | 2fi4.6 | 2fi4.7 | 2fi5.1 more...less...2fi5.2 | 2fi5.3 | 2fi5.4 | 2fi5.5 | 2fi5.6 | 2fi5.7 | 2ftl.1 | 2ftl.3 | 2ftl.4 | 2ftl.5 | 2ftm.1 | 2ftm.2 | 2ftm.3 | 2ftm.4 | 2ftm.5 | 2ftm.6 | 2hex.1 | 2hex.2 | 2ijo.1 | 2kai.1 | 2ptc.1 | 2ptc.2 | 2r9p.1 | 2r9p.2 | 2ra3.1 | 2ra3.2 | 2tgp.1 | 2tgp.2 | 2tgp.3 | 2tgp.4 | 2tpi.1 | 3btk.1 | 3btk.2 | 3btk.3 | 3fp6.1 | 3fp8.1 | 3gym.1 | 3gym.2 | 3ldi.1 | 3ldj.1 | 3ldj.2 | 3ldj.3 | 3ldm.1 | 3otj.1 | 3tpi.1 | 3tpi.2 | 3tpi.3 | 3tpi.4 | 3u1j.1 | 4dg4.1 | 4dg4.2 | 4dg4.3 | 4dg4.4 | 4pti.1 | 4wwy.1 | 4wwy.2 | 4y0y.1 | 5pti.1 | 6f1f.1 | 6f1f.2 | 6f1f.3 | 6f1f.4 | 6f1f.5 | 6f1f.6 | 6pti.1 | 9pti.1